pI: 9.1347 |
Length (AA): 829 |
MW (Da): 93659 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 10 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
215 | 438 | 1gdo (A) | 1 | 217 | 39.00 | 0 | 1 | 0.7 | -1.68 |
215 | 828 | 2bpl (A) | 1 | 607 | 32.00 | 0 | 1 | 1.26 | -1.4 |
63 | 160 | 1air (A) | 160 | 259 | 30.00 | 0.15 | 0.56 | 0.429215 | -0.03 |
215 | 829 | 4amv (A) | 1 | 608 | 31.00 | 0 | 1 | 1.19086 | -0.69 |
470 | 828 | 2zj3 (A) | 326 | 679 | 36.00 | 0 | 1 | 0.996052 | -1.41 |
519 | 817 | 2v4m (A) | 392 | 687 | 32.00 | 0 | 1 | 0.811976 | -0.91 |
205 | 819 | 4amv (A) | 1 | 608 | 32.00 | 0 | 1 | 1.22472 | -0.92 |
453 | 807 | 2poc (A) | 349 | 700 | 35.00 | 0 | 1 | 0.883655 | -0.99 |
454 | 809 | 3tbf (A) | 250 | 602 | 31.00 | 0 | 1 | 0.892876 | -1.17 |
460 | 818 | 2zj3 (A) | 326 | 679 | 36.00 | 0 | 1 | 1.00054 | -1.41 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | gametocyte, merozoite, early schizont, late schizont. | PlasmoDB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, sporozoite, early ring, late ring, late trophozoite, Oocyst, Ring, Female Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 32 hs, early trophozoite, Male Gametocyte. | Otto TD PlasmoDB Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | intra-erythrocytic - 24 hs, Sporozoite. | Otto TD Zanghi G |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Ortholog group members (OG5_126842)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G24090 | putative glucosamine-fructose-6-phosphate aminotransferase |
Babesia bovis | BBOV_IV000250 | glucosamine--fructose-6-phosphate aminotransferase |
Brugia malayi | Bm1_38025 | Glucosamine--fructose-6-phosphate aminotransferase, putative |
Candida albicans | CaO19.9186 | glucosamine-6-P synthase |
Candida albicans | CaO19.1618 | glucosamine-6-P synthase |
Caenorhabditis elegans | CELE_F07A11.2 | Protein F07A11.2, isoform B |
Caenorhabditis elegans | CELE_F22B3.4 | Protein F22B3.4 |
Cryptosporidium hominis | Chro.10420 | glucosamine-fructose-6-phosphate aminotransferase |
Cryptosporidium parvum | cgd1_3730 | glucosamine-fructose-6-phosphate aminotransferase |
Chlamydia trachomatis | CT_816 | glucosamine-fructose-6-phosphate aminotransferase |
Dictyostelium discoideum | DDB_G0286603 | glucosamine-fructose-6-phosphate aminotransferase |
Drosophila melanogaster | Dmel_CG12449 | Glutamine:fructose-6-phosphate aminotransferase 1 |
Drosophila melanogaster | Dmel_CG1345 | Glutamine:fructose-6-phosphate aminotransferase 2 |
Escherichia coli | b3729 | L-glutamine:D-fructose-6-phosphate aminotransferase |
Echinococcus granulosus | EgrG_000097800 | Glutamine:fructose 6 phosphate aminotransferase |
Entamoeba histolytica | EHI_029560 | glucosamine--fructose-6-phosphate aminotransferase, putative |
Echinococcus multilocularis | EmuJ_000097800 | Glutamine:fructose 6 phosphate aminotransferase |
Homo sapiens | ENSG00000131459 | glutamine-fructose-6-phosphate transaminase 2 |
Homo sapiens | ENSG00000198380 | glutamine--fructose-6-phosphate transaminase 1 |
Leishmania braziliensis | LbrM.06.0930 | glucosamine-fructose-6-phosphate aminotransferase, putative |
Leishmania donovani | LdBPK_060980.1 | glucosamine-fructose-6-phosphate aminotransferase, putative |
Leishmania infantum | LinJ.06.0980 | glucosamine-fructose-6-phosphate aminotransferase, putative |
Leishmania major | LmjF.06.0950 | glucosamine-fructose-6-phosphate aminotransferase, putative |
Leishmania mexicana | LmxM.06.0950 | glucosamine-fructose-6-phosphate aminotransferase, putative |
Loa Loa (eye worm) | LOAG_03315 | glucosamine-fructose-6-phosphate aminotransferase |
Mycobacterium leprae | ML0371 | Probable glucosamine-fructose-6-phosphate aminotransferase GlmS (Hexosephosphate aminotransferase) (D-fructose-6-phosphate amido |
Mus musculus | ENSMUSG00000020363 | glutamine fructose-6-phosphate transaminase 2 |
Mus musculus | ENSMUSG00000029992 | glutamine fructose-6-phosphate transaminase 1 |
Mycobacterium tuberculosis | Rv3436c | Probable glucosamine--fructose-6-phosphate aminotransferase [isomerizing] GlmS (hexosephosphate aminotransferase) (D-fructose-6- |
Mycobacterium ulcerans | MUL_0872 | glucosamine--fructose-6-phosphate aminotransferase |
Neospora caninum | NCLIV_031610 | Glucosamine--fructose-6-phosphate aminotransferase (Isomerizing) (EC 2.6.1.16), related |
Oryza sativa | 4351413 | Os12g0131100 |
Onchocerca volvulus | OVOC4684 |
|
Plasmodium berghei | PBANKA_0509300 | glutamine--fructose-6-phosphate aminotransferase [isomerizing], putative |
Plasmodium falciparum | PF3D7_1025100 | glutamine--fructose-6-phosphate aminotransferase [isomerizing], putative |
Plasmodium knowlesi | PKNH_0609600 | glutamine--fructose-6-phosphate aminotransferase [isomerizing], putative |
Plasmodium vivax | PVX_111455 | glutamine--fructose-6-phosphate aminotransferase [isomerizing], putative |
Plasmodium yoelii | PY00101 | glucosamine-fructose-6-phosphate aminotransferase |
Saccharomyces cerevisiae | YKL104C | glutamine--fructose-6-phosphate transaminase (isomerizing) GFA1 |
Schistosoma japonicum | Sjp_0034580 | ko:K00820 glucosamine--fructose-6-phosphate aminotransferase (isomerizing) [EC2.6.1.16], putative |
Schistosoma mansoni | Smp_136260 | family C44 unassigned peptidase (C44 family) |
Schmidtea mediterranea | mk4.044559.02 | |
Schmidtea mediterranea | mk4.044559.00 | |
Schmidtea mediterranea | mk4.001185.03 | |
Schmidtea mediterranea | mk4.001185.04 | |
Trypanosoma brucei gambiense | Tbg972.7.6450 | glucosamine-fructose-6-phosphate aminotransferase, putative |
Trypanosoma brucei | Tb927.7.5560 | glucosamine-fructose-6-phosphate aminotransferase, putative |
Trypanosoma cruzi | TcCLB.510303.200 | glucosamine-fructose-6-phosphate aminotransferase, putative |
Toxoplasma gondii | TGME49_231350 | glucosamine-fructose-6-phosphate aminotransferase |
Treponema pallidum | TP0861 | glucosamine--fructose-6-phosphate aminotransferase |
Theileria parva | TP02_0935 | glucosamine-fructose-6-phosphate aminotransferase, putative |
Trichomonas vaginalis | TVAG_478320 | glucosamine-fructose-6-phosphate aminotransferase, putative |
Trichomonas vaginalis | TVAG_011780 | glucosamine-fructose-6-phosphate aminotransferase, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0223 | glucosamine 6-phosphate synthetase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.7.5560 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.5560 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.5560 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.7.5560 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b3729 | Escherichia coli | essential | goodall |
CELE_F07A11.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F07A11.2 | Caenorhabditis elegans | sterile | wormbase |
CELE_F22B3.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F22B3.4 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F22B3.4 | Caenorhabditis elegans | sterile | wormbase |
YKL104C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0509300 | Plasmodium berghei | Slow | plasmo |
TGME49_231350 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.1
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | glutamine--fructose-6-phosphate transaminase 1 | Compounds | References |